Atlas Trials

The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients

Clinical trial NCT02822534 · UNKNOWN

Trial details

NCT number
NCT02822534
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2016-04-01
Primary completion
2016-07-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.